¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"specific therapy"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
age-specific death rate
¿¬·Éº°»ç¸Á·ü
age-specific fertility rate
¿¬·Éº°»ý½Ä·ü
age-specific rate
¿¬·Éº°ºñÀ²
cause-specific rate
¿øÀκ°ºñÀ²
donor-specific phage
Á¦°øÀÚÆ¯ÀÌÆÄÁö, °ø¿©ÀÚÆ¯ÀÌÆÄÁö
granulocyte-specific antigen
°ú¸³±¸Æ¯ÀÌÇ׿ø
group-specific
±ºÆ¯ÀÌ-
group-specific antigen
¹«¸®Æ¯ÀÌÇ׿ø, ±ºÆ¯ÀÌÇ׿ø
neuron-specific enolase
´º·±Æ¯ÀÌ¿¡³î¶ó¾ÆÁ¦
organ specific antigen
Àå±âƯÀÌÇ׿ø
platelet-specific antigen
Ç÷¼ÒÆÇƯÀÌÇ׿ø
prostate specific antigen
Àü¸³»ùƯÀÌÇ׿ø
species-specific
Á¾Æ¯ÀÌ-
species-specific antigen
Á¾Æ¯ÀÌÇ׿ø
species-specific reactivity
Á¾Æ¯À̹ÝÀÀ¼º
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
platelet-specific antigen
Ç÷¼ÒÆÇƯÀÌÇ׿ø
specific activity
ºñ¹æ»ç´É, ƯÀÌȰ¼ºµµ
specific gravity
ºñÁß
specific phobia
ƯÁ¤°øÆ÷(Áõ)
specific
ƯÀÌ-, ƯÁ¤-
therapy
¿ä¹ý
acetylsalycylic acid antiplatelet therapy
Ç×Ç÷¼ÒÆÇ¿ä¹ý
adjuvant therapy
º¸Á¶¿ä¹ý
antibiotic therapy
Ç×»ýÁ¦¿ä¹ý
ASA antiplatelet therapy
(¢¡acetylsalycylic acid antiplatelet therapy) Ç×Ç÷¼ÒÆÇ¿ä¹ý
behavioral therapy
Çൿ¿ä¹ý
electroconvulsive therapy
Àü±â°æ·Ã¿ä¹ý
estrogen replacement therapy
¿©¼ºÈ£¸£¸ó´ëü¿ä¹ý
gene therapy
À¯ÀüÀÚ¿ä¹ý
home oxygen therapy
°¡Á¤»ê¼Ò¿ä¹ý
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
age-specific rate
¿¬·Éº°Æ¯¼öÀ²
age-specific death rate
¿¬·Éº°Æ¯¼ö»ç¸Á·ü
age-specific fertility rate
¿¬·Éº°Ãâ»êÀ²
granulocyte-specific antigen
°ú¸³±¸Æ¯ÀÌÇ׿ø
group-specific antigen
±ºÆ¯ÀÌÇ׿ø
organ specific antigen
Àå±âƯÀÌÇ׿ø
platelet-specific antigen
Ç÷¼ÒÆÇƯÀÌÇ׿ø
specific action
ƯÀÌÀÛ¿ë
specific activity
ºñ¹æ»ç´É, ƯÀÌȰ¼ºµµ
specific antagonist
ƯÀÌ´ëÇ×Á¦
specific antigen
ƯÀÌÇ׿ø
specific pathogen free animal
ƯÁ¤¹«º´¿øÃ¼µ¿¹°
type specific antigen
ÇüƯÀÌÇ׿ø
blood group specific substance
Ç÷¾×ÇüƯÀ̹°Áú
cause-specific rate
¿øÀκ°Æ¯¼öÀ²
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
SDA= specific dynamic action
ƯÀ̵¿Àû ÀÛ¿ë.
age specific death rate
¿¬·Éº° »ç¸Á·ü
antigen, species-specific
Á¾Æ¯ÀÌÇ׿ø
antigen, tumor-specific
Á¾¾çƯÀÌÇ׿ø
antigen, tumor-specific transplantation
Á¾¾çƯÀÌ À̽ÄÇ׿ø
antigen,tumor-specific transplantation
Á¾¾ç ƯÀÌÀ̽Ä(ðþåË ÷åì¶ì¹ãÕ)
granulocyte-specific antigens
°ú¸³±¸Æ¯ÀÌÇ׿ø
group specific C carbohydrate
±ºÆ¯ÀÌ C´Ù´çü.
group-specific
±ºÆ¯ÀÌÀÇ
group-specific C carbohydrate
±ºÆ¯ÀÌ C ź¼öȹ°
group-specific antigen
±ºÆ¯ÀÌÇ׿ø
group-specific antigen
±º-ƯÀÌÇ׿ø
idiotype specific regulatory cell
°³º°Æ¯ÀÌÇü Á¶Àý¼¼Æ÷
immunity, specific
ƯÀ̸鿪
platelet-specific antigens
Ç÷¼ÒÆÇƯÀÌÇ׿ø
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
age specific death rate
¿¬·Éº° »ç¸Á·ü
antigen, species-specific
Á¾Æ¯ÀÌÇ׿ø
antigen, tumor-specific
Á¾¾çƯÀÌÇ׿ø
antigen, tumor-specific transplantation
Á¾¾çƯÀÌ À̽ÄÇ׿ø
antigen,tumor-specific transplantation
Á¾¾ç ƯÀÌÀ̽Ä(ðþåË ÷åì¶ì¹ãÕ)
blood group specific substance
Ç÷¾×ÇüƯÀ̹°Áú.
bulk specific gravity
¿ëÀûºñÁß(é»îÝÝïñì)
donor-specific phage
°ø¿©±ÕƯÀÌÆÄÁö
granulocyte-specific antigens
°ú¸³±¸Æ¯ÀÌÇ׿ø
group specific C carbohydrate
±ºÆ¯ÀÌ C´Ù´çü.
group-specific
±ºÆ¯ÀÌÀÇ
group-specific C carbohydrate
±ºÆ¯ÀÌ C ź¼öȹ°
group-specific antigen
±º-ƯÀÌÇ׿ø
group-specific antigen
±ºÆ¯ÀÌÇ׿ø
idiotype specific regulatory cell
°³º°Æ¯ÀÌÇü Á¶Àý¼¼Æ÷
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á
´ÙÀ½